Skip to main content
. 2020 Jun 29;8:e9435. doi: 10.7717/peerj.9435

Figure 4. Decision curve analysis (DCA).

Figure 4

When risk threshold is around 10–90%, the net benefit of application of the model on taking measures is greater than “treat-all-patient” or “treat-none” scheme. In addition, utilization of sex, urine culture, white blood cell (WBC) and albumin globulin ratio (AGR) alone is inferior than the model.